X Square Capital LLC Sells 226 Shares of Kimberly-Clark Co. (NYSE:KMB)

X Square Capital LLC cut its position in Kimberly-Clark Co. (NYSE:KMB) by 1.6% during the 2nd quarter, HoldingsChannel reports. The firm owned 13,679 shares of the company’s stock after selling 226 shares during the quarter. X Square Capital LLC’s holdings in Kimberly-Clark were worth $1,890,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the company. Rise Advisors LLC increased its position in shares of Kimberly-Clark by 926.3% during the first quarter. Rise Advisors LLC now owns 195 shares of the company’s stock worth $25,000 after acquiring an additional 176 shares in the last quarter. Crewe Advisors LLC bought a new stake in shares of Kimberly-Clark in the first quarter worth $27,000. New Millennium Group LLC acquired a new position in Kimberly-Clark during the second quarter worth $28,000. Strategic Financial Concepts LLC bought a new position in Kimberly-Clark in the second quarter valued at $32,000. Finally, Fortitude Family Office LLC increased its stake in Kimberly-Clark by 333.3% in the 2nd quarter. Fortitude Family Office LLC now owns 325 shares of the company’s stock valued at $45,000 after buying an additional 250 shares during the last quarter. 76.29% of the stock is owned by institutional investors.

Kimberly-Clark Trading Down 0.8 %

Shares of KMB stock opened at $146.91 on Monday. Kimberly-Clark Co. has a 12-month low of $116.32 and a 12-month high of $149.30. The firm has a 50 day moving average price of $141.51 and a two-hundred day moving average price of $134.71. The company has a quick ratio of 0.58, a current ratio of 0.85 and a debt-to-equity ratio of 5.59. The company has a market capitalization of $49.48 billion, a PE ratio of 27.01, a price-to-earnings-growth ratio of 3.12 and a beta of 0.39.

Kimberly-Clark (NYSE:KMB) last released its quarterly earnings results on Tuesday, July 23rd. The company reported $1.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.71 by $0.25. Kimberly-Clark had a return on equity of 223.55% and a net margin of 11.28%. The business had revenue of $5.03 billion during the quarter, compared to the consensus estimate of $5.10 billion. During the same period in the previous year, the company posted $1.65 EPS. The firm’s quarterly revenue was down 2.0% on a year-over-year basis. As a group, analysts predict that Kimberly-Clark Co. will post 7.25 earnings per share for the current year.

Kimberly-Clark Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 2nd. Investors of record on Friday, September 6th will be paid a $1.22 dividend. The ex-dividend date is Friday, September 6th. This represents a $4.88 annualized dividend and a dividend yield of 3.32%. Kimberly-Clark’s dividend payout ratio (DPR) is presently 89.71%.

Insider Buying and Selling

In other Kimberly-Clark news, insider Gonzalo Uribe sold 1,780 shares of the business’s stock in a transaction dated Monday, July 29th. The shares were sold at an average price of $140.84, for a total value of $250,695.20. Following the completion of the sale, the insider now owns 7,377 shares of the company’s stock, valued at approximately $1,038,976.68. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, insider Gonzalo Uribe sold 1,780 shares of Kimberly-Clark stock in a transaction that occurred on Monday, July 29th. The shares were sold at an average price of $140.84, for a total value of $250,695.20. Following the completion of the sale, the insider now directly owns 7,377 shares in the company, valued at $1,038,976.68. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, insider Jeffrey P. Melucci sold 37,699 shares of the business’s stock in a transaction that occurred on Thursday, July 25th. The shares were sold at an average price of $141.42, for a total value of $5,331,392.58. Following the completion of the sale, the insider now owns 19,935 shares of the company’s stock, valued at $2,819,207.70. The disclosure for this sale can be found here. 0.62% of the stock is owned by insiders.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on KMB shares. Argus upgraded Kimberly-Clark to a “hold” rating in a report on Friday, July 26th. BNP Paribas assumed coverage on Kimberly-Clark in a research report on Monday, June 24th. They set a “neutral” rating and a $146.00 price target on the stock. JPMorgan Chase & Co. upped their price objective on Kimberly-Clark from $123.00 to $135.00 and gave the stock an “underweight” rating in a research note on Monday, July 22nd. TD Cowen assumed coverage on shares of Kimberly-Clark in a research note on Tuesday, July 23rd. They issued a “buy” rating and a $161.00 target price for the company. Finally, Deutsche Bank Aktiengesellschaft upped their price target on shares of Kimberly-Clark from $139.00 to $142.00 and gave the stock a “hold” rating in a research report on Wednesday, July 24th. Two equities research analysts have rated the stock with a sell rating, eight have given a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat.com, Kimberly-Clark presently has an average rating of “Hold” and a consensus target price of $145.67.

About Kimberly-Clark

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company's Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.